Jonas Andersson

3.9k total citations
42 papers, 823 citations indexed

About

Jonas Andersson is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Physiology. According to data from OpenAlex, Jonas Andersson has authored 42 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 10 papers in Epidemiology and 10 papers in Physiology. Recurrent topics in Jonas Andersson's work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Adipose Tissue and Metabolism (5 papers). Jonas Andersson is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Adipose Tissue and Metabolism (5 papers). Jonas Andersson collaborates with scholars based in Sweden, Denmark and United Kingdom. Jonas Andersson's co-authors include Tommy Olsson, Peter Arner, Fredrik Karpe, Kerstin Wåhlén, Kurt Boman, Elisabet Arvidsson Nordström, Lennart Blomqvist, Ingrid Dahlman, Maria Wennberg and Bernt Lindahl and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and International Journal of Molecular Sciences.

In The Last Decade

Jonas Andersson

40 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Andersson Sweden 16 332 264 223 115 115 42 823
Ako Fukami Japan 17 192 0.6× 160 0.6× 211 0.9× 109 0.9× 186 1.6× 50 748
Joanna Janowska Poland 16 321 1.0× 427 1.6× 234 1.0× 160 1.4× 96 0.8× 53 983
Tiziana Di Chiara Italy 19 271 0.8× 207 0.8× 321 1.4× 168 1.5× 202 1.8× 50 868
Fotios Iliadis Greece 16 310 0.9× 253 1.0× 226 1.0× 120 1.0× 270 2.3× 30 954
Miguel Valle Spain 17 297 0.9× 312 1.2× 140 0.6× 118 1.0× 221 1.9× 24 913
Merja Santaniemi Finland 15 314 0.9× 502 1.9× 197 0.9× 182 1.6× 209 1.8× 22 911
Russ Tracy United States 6 169 0.5× 138 0.5× 191 0.9× 80 0.7× 108 0.9× 9 732
Niina Siitonen Finland 11 181 0.5× 188 0.7× 170 0.8× 121 1.1× 82 0.7× 13 631
Gail Yee United States 10 483 1.5× 422 1.6× 338 1.5× 182 1.6× 155 1.3× 11 880
Yuji Hirai Japan 16 167 0.5× 151 0.6× 252 1.1× 99 0.9× 198 1.7× 23 802

Countries citing papers authored by Jonas Andersson

Since Specialization
Citations

This map shows the geographic impact of Jonas Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Andersson more than expected).

Fields of papers citing papers by Jonas Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Andersson. The network helps show where Jonas Andersson may publish in the future.

Co-authorship network of co-authors of Jonas Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Andersson. A scholar is included among the top collaborators of Jonas Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Andersson. Jonas Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svensson, Per, Stefan Söderberg, Ingvar A. Bergdahl, et al.. (2024). Seroprevalence of Helicobacter pylori and incident myocardial infarction - A population-based Swedish nested case–control study. International Journal of Cardiology. 421. 132917–132917.
2.
Andersson, Jonas, Maria Nordendahl, Maria Wennberg, et al.. (2024). Thirty-six-year trends (1986–2022) in cigarette smoking and snus use in northern Sweden: a cross-sectional study. BMJ Open. 14(12). e088162–e088162. 1 indexed citations
3.
Lind, Marcus, et al.. (2023). Diabetes, prediabetes, and atrial fibrillation—A population‐based cohort study based on national and regional registers. Journal of Internal Medicine. 294(5). 605–615. 5 indexed citations
4.
Müller, Christian, Bastian Stoffers, Mélanie Waldenberger, et al.. (2022). G Protein-Coupled Receptor 15 Expression Is Associated with Myocardial Infarction. International Journal of Molecular Sciences. 24(1). 180–180. 7 indexed citations
5.
Andersson, Jonas, et al.. (2022). CTH G1208T and MTHFR A1298C polymorphisms are associated with a higher risk of a first myocardial infarction with fatal outcome among women. Drug Metabolism and Personalized Therapy. 38(1). 57–63. 2 indexed citations
6.
7.
8.
Lind, Marcus, et al.. (2020). Alcohol consumption and risk of incident atrial fibrillation: A population-based cohort study. European Journal of Internal Medicine. 76. 50–57. 17 indexed citations
9.
Andersson, Jonas, et al.. (2020). GDF-15 is associated with sudden cardiac death due to incident myocardial infarction. Resuscitation. 152. 165–169. 19 indexed citations
10.
Bodén, Stina, Maria Wennberg, Bethany Van Guelpen, et al.. (2017). Dietary inflammatory index and risk of first myocardial infarction; a prospective population-based study. Nutrition Journal. 16(1). 21–21. 90 indexed citations
11.
Dahlqvist, Erik, et al.. (2017). Incidence, type of atrial fibrillation and risk factors for stroke: a population-based cohort study. Clinical Epidemiology. Volume 9. 53–62. 20 indexed citations
12.
Völz, Sebastian, Jonas Spaak, Johan Elf, et al.. (2017). Renal sympathetic denervation in Sweden. Journal of Hypertension. 36(1). 151–158. 22 indexed citations
13.
Andersson, Jonas, Mårten Rosenqvist, Per Tornvall, & Kurt Boman. (2014). NT-proBNP predicts maintenance of sinus rhythm after electrical cardioversion. Thrombosis Research. 135(2). 289–291. 10 indexed citations
14.
Höglund, Niklas, Jonas Andersson, Henrik Almroth, et al.. (2012). The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin. International Journal of Cardiology. 167(5). 2088–2091. 4 indexed citations
15.
Andersson, Jonas, Henrik Almroth, Niklas Höglund, et al.. (2011). Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion. Thrombosis Research. 127(3). 189–192. 2 indexed citations
16.
Wnuk, Krzysztof, et al.. (2009). An industrial case study on large-scale variability management for product configuration in the mobile handset domain. Lund University Publications (Lund University). 29. 155–164. 1 indexed citations
17.
Andersson, Jonas, Lars Johansson, Per Ladenvall, et al.. (2009). C-Reactive Protein Is a Determinant of First-Ever Stroke: Prospective Nested Case-Referent Study. Cerebrovascular Diseases. 27(6). 544–551. 43 indexed citations
18.
Andersson, Jonas, Jan-Håkan Jansson, Gideon Hellsten, et al.. (2009). Effects of heavy endurance physical exercise on inflammatory markers in non-athletes. Atherosclerosis. 209(2). 601–605. 37 indexed citations
19.
Mattsson, Cecilia, Eva Rask, Kjell Carlström, et al.. (2007). Gender‐specific Links Between Hepatic 11β Reduction of Cortisone and Adipokines. Obesity. 15(4). 887–894. 4 indexed citations
20.
Andersson, Jonas, et al.. (1996). Valvular function of peripheral veins after hyperemic dilation. Journal of Vascular Surgery. 23(4). 611–615. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ako Fukami Breakdown of academic impact, for papers by Joanna Janowska Breakdown of academic impact, for papers by Tiziana Di Chiara Breakdown of academic impact, for papers by Fotios Iliadis Breakdown of academic impact, for papers by Miguel Valle Breakdown of academic impact, for papers by Merja Santaniemi Breakdown of academic impact, for papers by Russ Tracy Breakdown of academic impact, for papers by Niina Siitonen Breakdown of academic impact, for papers by Gail Yee Breakdown of academic impact, for papers by Yuji Hirai
Rankless by CCL
2026